| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 40.495 | 22.268 | 0 | 51.574 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 40.508 | 22.278 | 0 | 51.574 | 0 | 0 | 0 | 1 | 0 | 0 |
| Total Expenses - EUR | 92 | 60 | 173 | 459 | 1.840 | 91 | 97 | 136 | 223 | 31 |
| Gross Profit/Loss - EUR | 40.416 | 22.219 | -173 | 51.115 | -1.840 | -91 | -97 | -135 | -223 | -31 |
| Net Profit/Loss - EUR | 39.201 | 21.550 | -173 | 50.599 | -1.840 | -91 | -97 | -135 | -223 | -31 |
| Employees | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Intemed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 39.269 | 39.107 | 21.065 | 72.182 | 68.057 | 66.676 | 65.101 | 8.507 | 5.285 | 5.229 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 13.361 | 11 | 51.584 | 15 | 15 | 14 | 14 | 5.259 | 5.229 |
| Cash | 39.269 | 25.746 | 21.055 | 20.598 | 68.043 | 66.662 | 65.086 | 8.493 | 26 | 0 |
| Shareholders Funds | 39.246 | 21.604 | 21.065 | 71.278 | 68.057 | 66.676 | 65.101 | 5.525 | 5.285 | 5.225 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 23 | 17.503 | 0 | 904 | 0 | 0 | 0 | 2.982 | 0 | 4 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8240 - 8240" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Intemed S.r.l.